The German pharmaceutical-and-agricultural group said the acquisition would complement its drug pipeline and leverage its ophthalmology footprint.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Date:
More like thisRelated
The Cattle Empire That Turned Out to Be a Giant Ponzi Scheme
Investors and bank loans fueled Brian McClain’s ‘house of...
Missing Auburn University student in Japan found dead, mother says: “Unimaginable loss”
Missing Auburn University engineering student...
Albuquerque hosts 5th annual 'Touch-a-Truck' event
ALBUQUERQUE, N.M. (KRQE) — Families across the metro gathered for...